TOKYO (Reuters) – Takeda Pharmaceutical Co Ltd has sounded out creditors for loans, sources with direct knowledge of the matter said, as it moves closer to making a bid for London-listed rare disease specialist Shire that could top $40 billion.

Source: Reuters